HOME >> MEDICINE >> NEWS
Vascular structure and function improve with diet and exercise

high-normal blood pressure (systolic greater than 130 mmHg to 139 mmHg, diastolic greater than 85 mmHg to 89 mmHg) or pre-diabetes indicated by impaired fasting glucose or impaired glucose tolerance. The average age of patients was 53.3 years.

Researchers found that the 22 female and 16 male participants lost weight and improved their exercise capacity on the program. Treadmill tests were used to measure exercise capacity (VO2 max, the maximal volume of oxygen exchanged during exercise) at the beginning and end of the eight-week period. Average VO2 max increased from 32.1 milliliters per minute per kilogram (mL/min/kg) to 35.3 mL/min/kg. Average body weight decreased from 92.5 kg to 90.9 kg (203.5 pounds to 200 pounds).

"We were surprised that we saw such a weight reduction with the Mediterranean diet," Petrella said. "It was not a weight reduction program."

Blood pressure did not change significantly.

Ultrasound measurements of the heart and blood vessels at rest were performed as well.

Left ventricular diastolic filling (LVDF) measurements indicate the efficiency of the heart to relax. Left ventricular mass is a measure of end organ damage often following the onset of LVDF abnormalities.

The brachial (arm) and carotid (neck) arteries were tested for intima-media thickness and arterial distensibility. Both reflect the health of the blood vessels. The thicker and less distensible (elastic) the arteries are, the greater the load on the heart. This often results from changes in blood pressure, blood glucose or cholesterol disorders such as dyslipidemia.

Carotid artery distensibility was the only structural factor that significantly improved. It rose about 16 percent. Petrella said that the other factors may improve as patients are followed for one year.

One in three American adults has high blood pressure and two-thirds to three-fourths of people with diabetes mellitus die of some form of heart or blood vessel
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
30-Apr-2005


Page: 1 2 3

Related medicine news :

1. Vascular disease most common cause of male erectile dysfunction
2. Better insight into brain anatomical structures
3. Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients
4. Brain structure changes years before memory loss begins
5. Biologists learn structure of enzyme needed to power molecular motor
6. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
7. IEEE-USA launches critical infrastructure protection committee
8. Molecular structure reveals how botulinum toxin attaches to nerve cells
9. Chemotherapy temporarily affects the structures of the human brain
10. Sandia work launched on space shuttle shows live cells influence growth of nanostructures
11. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vascular structure and function improve with diet and exercise

(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: